Search Results - "Richez, Michel"

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party by Berghmans, Thierry, Ameye, Lieveke, Lafitte, Jean-Jacques, Colinet, Benoît, Cortot, Alexis, CsToth, Ingrid, Holbrechts, Stéphane, Lecomte, Jacques, Mascaux, Céline, Meert, Anne-Pascale, Paesmans, Marianne, Richez, Michel, Scherpereel, Arnaud, Tulippe, Christian, Willems, Luc, Dernies, Tiffany, Leclercq, Nathalie, Sculier, Jean-Paul

“…Cisplatin doublets are standard 1st line treatment for advanced non-small cell lung cancer (NSCLC), without accurate predictor for response and survival, but…”
Get full text

Guidelines of clinical practice made by the European Lung Cancer Working Party: updates by Berghmans, Thierry, Cortot, Alexis, CsToth, Ingrid, Garcia, Camilo, Giner-Marco, Vicente, Grigoriu, Bogdan, Holbrechts, Stéphane, Lafitte, Jean-Jacques, Meert, Anne-Pascale, Moretti, Luigi, Paesmans, Marianne, Remmelink, Myriam, Richez, Michel, Roelandts, Martine, Scherpereel, Arnaud, Tulippe, Christian, Van Houtte, Paul, Sculier, Jean-Paul

Get full text

Fluorescence Bronchoscopy in High-Risk Patients: A Comparison of LIFE and Pentax Systems by Pierard, Philippe, Martin, Benoît, Verdebout, Jean-Marc, Faber, Jean, Richez, Michel, Sculier, Jean-Paul, Ninane, Vincent

Get full text